SPC Global Holdings Lifts Earnings with Shift to Higher-Margin Products

SPC Global boosts margins and cuts debt, but remains loss-making with ambitious FY27 targets.

What the company is saying

SPC Global frames its FY26 results as a successful pivot to higher-margin branded products, highlighting a 27% rise in normalised EBITDA to $38.5m and improved free cash flow outflow of $4.1m. The company emphasizes that EBITDA growth exceeded its own 25% guidance and that more than $20m in synergies have been delivered. Management points to a $100m equity raising as transformative, reducing net debt to $85.8m and leverage to around two times EBITDA. Forward-looking statements focus on operational changes expected to deliver $8m in EBITDA benefits in FY27, with annualised benefits above $11m and a payback of less than 12 months. The narrative is optimistic, stressing targets of over 10% NSR growth and more than 20% EBITDA growth for FY27, alongside ambitions for positive free cash flow and further leverage reduction. International expansion is presented as a growth lever, with new commercial arrangements and a memorandum of understanding for Middle Eastern distribution, though financial impacts are not quantified.

What the data suggests

Actual FY26 results show net sales revenue fell to $331.8m from $376.2m, reflecting the exit from lower-return private-label volumes. Despite this, normalised EBITDA increased to $38.5m from $30.3m, and domestic EBITDA rose to $22.8m from $16.7m, indicating margin improvement. Free cash flow remains negative at a $4.1m outflow, but this is a substantial improvement from the prior $22.9m outflow. Net debt dropped to $85.8m from $123.7m after the $100m equity raise, halving net leverage from four times to around two times EBITDA. International NSR declined 12.5% to $45.9m, but contribution margin rose to 60.2% from 47.1%, and international EBITDA improved to $15.7m from $13.6m. The company remains loss-making, with a normalised net loss after tax of $11.6m, nearly unchanged from $11.5m in FY25. Most forward-looking claims—such as $8m in FY27 EBITDA benefits, $37m export ambition, and positive free cash flow—are targets or projections, not realised outcomes.

Analysis

The announcement presents a positive tone, highlighting improvements in EBITDA, margins, and leverage, all supported by disclosed numerical data. However, while profitability metrics (EBITDA, free cash flow, net loss) are disclosed, the company remains loss-making and free cash flow is still negative, albeit improved. Several key claims—such as targeted NSR and EBITDA growth, positive free cash flow, and leverage reduction—are forward-looking and not yet realised, though they are set for the next financial year (FY27), making the execution distance near-term. The $100m equity raising is a significant capital outlay, and while it has reduced leverage, the benefits of operational changes and synergies are only partially realised, with further gains expected. The narrative is somewhat inflated by ambitious targets and references to 'ambitions' and 'expected' benefits, but the majority of the positive claims are grounded in actual results. The gap between narrative and evidence is moderate: realised improvements are clear, but future benefits are not guaranteed and are presented optimistically.

Risk flags

• ●The company remains loss-making, with a normalised net loss after tax of $11.6m in FY26, essentially flat from $11.5m in FY25. Continued losses raise questions about the sustainability of the business model and the achievability of positive free cash flow targets.
• ●Free cash flow, while improved, is still negative at a $4.1m outflow. Persistent negative cash flow could require further capital raising if operational improvements or targets are not met.
• ●Aspirational targets for FY27—such as greater than 10% NSR growth, more than 20% EBITDA growth, and positive free cash flow—are not yet supported by realised results. Delivery risk is heightened by reliance on operational changes, new commercial arrangements, and international expansion, none of which have demonstrated financial impact in the current period.
• ●The $100m equity raising reduced leverage, but the company’s ability to further lower net leverage to between one and 1.2 times EBITDA by end-FY27 depends on delivering both EBITDA growth and cash flow improvements. If targets are missed, leverage could remain elevated.
• ●Several commercial initiatives, including the memorandum of understanding for Middle Eastern distribution and the $37m export ambition, are not backed by binding contracts or disclosed financial terms. This introduces uncertainty around the timing and magnitude of any revenue contribution.

Bottom line

SPC Global’s FY26 results show clear margin improvement and reduced leverage, but the business is still loss-making and free cash flow remains negative. The company’s narrative is supported by delivered EBITDA growth and synergy benefits, yet most of the upside is tied to ambitious FY27 targets that are not yet realised. The $100m equity raise has strengthened the balance sheet, but further progress depends on executing operational changes and converting commercial ambitions into actual revenue and profit. Investors should focus on whether SPC Global can deliver positive free cash flow and meet its EBITDA and leverage targets in FY27. The most important takeaway is that while operational discipline has improved margins, the pathway to sustainable profitability and cash generation is not yet proven.

Announcement summary

(ASX: SPG) SPC Global Holdings reported net sales revenue (NSR) of $331.8 million for FY26, down from $376.2m as it deliberately moved away from lower-return volume towards higher-margin branded products. Normalised EBITDA rose 27% to $38.5m from $30.3m, exceeding SPC Global’s 25% growth guidance as both its domestic and international businesses improved margins. Free cash flow improved to a $4.1m outflow from $22.9m a year earlier, while the normalised net loss after tax was broadly steady at $11.6m compared with $11.5m in FY25. A fully underwritten $100m equity raising completed in May reduced net debt to $85.8m from $123.7m and cut net leverage from four times EBITDA to around two times. Domestic NSR declined to $287.7m from $325.4m as private-label volumes were reduced, but EBITDA increased to $22.8m from $16.7m through tighter promotional discipline and a greater weighting towards branded, higher-margin products. International NSR fell 12.5% to $45.9m as SPC Global moved away from lower-margin manufacturing arrangements, while its sales contribution margin increased to about 60.2% from 47.1% and EBITDA rose to $15.7m from $13.6m. More than $20m of synergy benefits have been delivered through procurement, supply chain productivity, overhead reductions and commercial cross-selling, with the broader integration program remaining on track.

Disagree with this article?